Results 241 to 250 of about 63,205 (262)

INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE

2008
GANDHI VIRAJKUMAR B, GIRANDA VINCENT L, GONG JIANCHUN, PENNING THOMAS D, ZHU GUI-DONG   +4 more
openaire   +4 more sources

Poly(ADP-ribose) polymerase 1 is a novel target to promote axonal regeneration

Proceedings of the National Academy of Sciences of the United States of America, 2015
Dianna Willis, Brett Langley, Camille Brochier   +2 more
exaly  

TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE

2014
SHEN WANG, MAUNG JACK, ZHANG AIMIN, ZHENG XIAOLING   +3 more
openaire   +5 more sources

POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS

2011
BROWN JASON W, GANGLOFF ANTHONY R, KIRYANOV ANDRE A   +2 more
openaire   +4 more sources

Poly(ADP-ribose) Polymerase

2006
openaire   +1 more source

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Jennifer Litton, Nicolas Sayegh, Chadi Hage Chehade   +2 more
exaly  

Poly(ADP-ribose) (PAR) polymer is a death signal

Proceedings of the National Academy of Sciences of the United States of America, 2006
Valina Dawson, Shaida Andrabi, Guy Poirier   +2 more
exaly  

Poly(ADP-ribose)polymerase: a perplexing participant in cellular responses to DNA breakage

Mutation Research - Reviews in Genetic Toxicology, 1991
James E Cleaver, William F Morgan, J E Cleaver   +2 more
exaly  

POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS

2010
BROWN JASON W, GANGLOFF ANTHONY R, JENNINGS ANDREW JOHN, VU PHONG H   +3 more
openaire   +4 more sources

Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future Implications

Cancers, 2019
Renuka Iyer, Christos Fountzilas, Fountzilas Christos   +2 more
exaly